Using of emollients in children with atopic dermatitis (literature review)
DOI:
https://doi.org/10.15574/SP.2023.129.65Keywords:
emollients, children, allergy, skin, atopic dermatitisAbstract
Modern external pharmacotherapy of atopic dermatitis in children should be etiopathogenetic and effects on the mechanisms of formation of allergic inflammation. External therapy of atopic dermatitis in children consists in the local application of emollients, glucocorticosteroids, antileukotriene, antihistamine medications, topical calcineurin inhibitors, in the case of complicated forms - antibacterial, antifungal, antiviral medications along with skin care. Eliminating dryness of the skin is the most important part of the external therapy of atopic dermatitis. Emollients are the main agents of the basic external therapy of atopic dermatitis, which perform the role of restoring and protecting the stratum corneum of the epidermis, maintaining hydro-lipid balance and preventing transepidermal water loss, reduce dryness, itching and peeling, have a glucocorticoid-saving effect, are used to achieve and maintain control over the symptoms of the disease. Emollients contain lipids and work through occlusion, trapping natural moisture in the skin, and/or through the properties of a humectant component that draws water from the dermis into the epidermis. Emollients are combined with local and systemic therapy of atopic dermatitis of any degree of severity, it should be used independently in the period of remission, increasing the duration of remission and preventing relapses.
Purpose - to increase the awareness of doctors and patients about the current features of the use of emollients in atopic dermatitis in children.
The use of emollients together with hydration and cleaning of the skin contributes to the restoration and preservation of a skin barrier function, reduces susceptibility to irritants and allergens. Emollients soften, smooth and rehydrate the skin, which helps to reduce unpleasant sensations, dryness, itching, inflammation at atopic dermatitis in children. A wide range of dosage forms of emollients, including cleansing agents for washing (gels, foams/mousses, soaps, solutions), as well as non-rinsable agents (lotions, creams, ointments, oils, emulsions), makes this group of medications available for a large number of patients with various clinical situations. Emollients can be used independently, as well as as adjuvant therapy with other topical or systemic agents at atopic dermatitis in children. The effective use of emollients improves the condition of the skin and has a positive effect on the quality of life.
No conflict of interests was declared by the authors.
References
Bellemere G, Boyer G, Belilovsky CDe, Baudouin C. (2019). Prevention of atopic dermatitis using emollients for 6 months - Follow-up for 24 months. Journal of Investigative Dermatology. 139 (5): 97. URL: https://www.sciencedirect.com/science/article/pii/S0022202X19308309. https://doi.org/10.1016/j.jid.2019.03.639
Butala S, Paller AS. (2022). Optimizing topical management of atopic dermatitis. Annals of Allergy, Asthma & Immunology. 128 (5): 488-504. URL: https://www.sciencedirect.com/science/article/pii/S1081120622001788. https://doi.org/10.1016/j.anai.2022.03.004; PMid:35288275
Chalmers JR, Haines RH, Bradshaw LE, Montgomery AA, Thomas KS, Brown SJ, Ridd MJ et al. (2020). Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. The Lancet. 395 (10228): 962-972. URL: https://www.sciencedirect.com/science/article/pii/S0140673619329848. https://doi.org/10.1016/S0140-6736(19)32984-8; PMid:32087126
Cheng BT, Patel MS, Xu M, Tilley CC, Zee PC, Paller AS, Fishbein AB. (2022). Timing of itch among children with atopic dermatitis. Annals of Allergy, Asthma & Immunology. 128 (5): 603-605. URL: https://www.sciencedirect.com/science/article/pii/S1081120622000898. https://doi.org/10.1016/j.anai.2022.01.042; PMid:35131408
Elias PM. (2022). Optimizing emollient therapy for skin barrier repair in atopic dermatitis. Annals of Allergy, Asthma & Immunology. 128 (5): 505-511. URL: https://www.sciencedirect.com/science/article/pii/S1081120622000151. https://doi.org/10.1016/j.anai.2022.01.012; PMid:35065300
Leung DY, Paller AS, Guttman-Yassky E. (2022). New therapies for atopic dermatitis: How will they impact skin care? Annals of Allergy, Asthma & Immunology. 128 (4): 344-345. URL: https://www.sciencedirect.com/science/article/pii/S1081120622000448. https://doi.org/10.1016/j.anai.2022.01.023; PMid:35093553
Mochulska OM, Boyarchuk OR, Kinash MI, Vorontsova TO, Volyanska LA. (2021). Effects of vitamins A, E, D, disorders of their metabolism and assessment of vitamin levels in children. Modern pediatrics. Ukraine. 2 (114): 58-66. URL: https://med-expert.com.ua/journals/ua/efekti-vitaminiv-e-d-porushennja-ih-obminu-ta-ocinka-rivnja-vitaminnoi-zabezpechenosti-v-ditej-ogljad-literaturi/. https://doi.org/10.15574/SP.2021.114.58
Mochulska OM, Kosovska ТМ. (2021). Systemic therapy of allergic dermatoses in children (literature review). Modern pediatrics. Ukraine. 1 (113): 62-67. URL: https://med-expert.com.ua/journals/ua/sistemna-terapija-alergodermatoziv-u-ditej-ogljad-literaturi/. https://doi.org/10.15574/SP.2021.113.62
Mochulska OM. (2020). External therapy of allergic dermatoses in children (literature review). Ukrainian journal Perinatology and Pediatrics. 4 (84): 41-47. URL: https://med-expert.com.ua/journals/ua/zovnishnja-terapija-alergodermatoziv-u-ditej-ogljad-literaturi/. https://doi.org/10.15574/PP.2020.84.41
Nadeau K, Sindher S, Berdyshev E, Shojinaga M, Alkotob S, Alonzi S, Varadharajulu S, Chandra S, Chinthrajah S, Brough H, Chan S, Lack G, Leung D. (2020). Skin TEWL results show significant improvements with Trilipid emollient compared to controls in infants and young children. Journal of Allergy and Clinical Immunology. 145 (2): 240. URL: https://www.sciencedirect.com/science/article/pii/S009167491931838X. https://doi.org/10.1016/j.jaci.2019.12.136
Paller AS, Guttman-Yassky E, Schuttelaar ML, Irvine AD, Antila M, Baselga E, Kataoka Y, Bruin-Weller MS, Marcoux D, Abramova A, Rizova E, Liu C, Zhang A. (2022). Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry. Journal of the American Academy of Dermatology. 87 (5): 1104-1108. URL: https://www.sciencedirect.com/science/article/pii/S0190962222000925. https://doi.org/10.1016/j.jaad.2022.01.018; PMid:35081419
Perrett KP, Peters RL. (2020). Emollients for prevention of atopic dermatitis in infancy. The Lancet. 395 (10228): 923-924. URL: https://www.sciencedirect.com/science/article/pii/S0140673619331745. https://doi.org/10.1016/S0140-6736(19)33174-5; PMid:32087123
Prasannanjaneyulu V, Nene S, Jain H, Nooreen R, Otavi S, Chitlangya P, Srivastava S. (2022). Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis. Cytokine & Growth Factor Reviews. 65: 12-26. URL: https://www.sciencedirect.com/science/article/pii/S1359610122000296. https://doi.org/10.1016/j.cytogfr.2022.04.007; PMid:35550114
Ridd MJ, Santer M, MacNeill SJ, Sanderson E, Wells S et al. (2022). Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial. The Lancet Child & Adolescent Health. 6 (8): 522-532. URL: https://www.sciencedirect.com/science/article/pii/S2352464222001468. https://doi.org/10.1016/S2352-4642(22)00146-8; PMid:35617974
Skjerven HO, Rehbinder EM, Vettukattil R, Le-Blanc M, Granum B, Haugen G, Hedlin G et al. (2020). Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. The Lancet. 395 (10228): 951-961. URL: https://www.sciencedirect.com/science/article/pii/S0140673619329836. https://doi.org/10.1016/S0140-6736(19)32983-6; PMid:32087121
Young TK, Glick AF., Yin HS, Kolla AM, Velazquez JJ, Nicholson J, Oza VS. (2021). Management of Pediatric Atopic Dermatitis by Primary Care Providers: A Systematic Review. Academic Pediatrics. 21 (8): 1318-1327. URL: https://www.sciencedirect.com/science/article/pii/S1876285921003612. https://doi.org/10.1016/j.acap.2021.07.008; PMid:34280477
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
